title: Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.
abstract: Immunity to Campylobacter jejuni, a major diarrheal pathogen, is largely Penner serotype specific. For broad protection, a vaccine should be based on a common antigen(s) present in all strains. In our previous study (M. J. Albert, S. Haridas, D. Steer, G. S. Dhaunsi, A. I. Smith, and B. Adler, Infect. Immun. 75:3070-3073, 2007), we demonstrated that antibody to cholera toxin (CT) cross-reacted with the major outer membrane proteins (MOMPs) of all Campylobacter jejuni strains tested. In the current study, we investigated whether immunization with CT protects against intestinal colonization by C. jejuni in an adult mouse model and whether the nontoxic subunit of CT (CT-B) is the portion mediating cross-reaction. Mice were orally immunized with CT and later challenged with C. jejuni strains (48, 75, and 111) of different serotypes. Control animals were immunized with phosphate-buffered saline. Fecal shedding of challenge organisms was studied daily for 9 days. Serum and fecal antibody responses were studied by enzyme-linked immunosorbent assay (ELISA) and immunoblotting. The cross-reactivity of rabbit CT-B antibody to MOMP was studied by immunoblotting. The reactivity of 21 overlapping 30-mer oligopeptides (based on MOMP's sequence) against rabbit CT antibody was tested by ELISA. Test animals produced antibodies to CT and MMP in serum and feces and showed resistance to colonization, the vaccine efficacies being 49% (for strain 48), 37% (for strain 75), and 34% (for strain 111) (P, ≤0.05 to ≤0.001). One peptide corresponding to a variable region of MOMP showed significant reactivity. CT-B antibody cross-reacted with MOMP. Since CT-B is a component of oral cholera vaccines, it might be possible to control C. jejuni diarrhea with these vaccines.
  
  
  OBJECTIVE
  Campylobacter jejuni is a major cause of diarrhea worldwide. Patients who recover from C. jejuni diarrhea develop immunity to the infecting serotype and remain susceptible to infection with other serotypes. A vaccine based on a common protective antigen(s) present in all C. jejuni serotypes is expected to provide broad protection. In our previous study, we showed that antibody to cholera toxin (CT) reacted with the major outer membrane proteins (MOMPs) from different strains of C. jejuni. We assumed that the B subunit of the toxin (CT-B), which is nontoxic and a component of licensed oral cholera vaccines, might be the component that cross-reacts with MOMP. In the current study, we showed that orally immunizing mice with CT protected them against colonization upon challenge with different serotypes of C. jejuni. We also showed that CT-B is the component mediating cross-reaction. Therefore, it might be possible to use cholera vaccines to prevent C. jejuni diarrhea. This could result in significant savings in vaccine development and treatment of the disease.
authors: Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait. john@hsc.edu.kw
authors: M John
authors: MJ
authors: Albert
authors: Abu Salim
authors: AS
authors: Mustafa
authors: Anjum
authors: A
authors: Islam
authors: Shilpa
authors: S
authors: Haridas
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis / Q000097:blood; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology; D057138:Bacterial Shedding; D002169:Campylobacter Infections / Q000276:immunology / Q000517:prevention & control*; D016123:Campylobacter jejuni / Q000276:immunology*; D002772:Cholera Toxin / Q000276:immunology*; D022121:Cholera Vaccines / Q000008:administration & dosage / Q000276:immunology*; D056738:Cross Protection; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces / Q000737:chemistry / Q000382:microbiology; D005260:Female; D007114:Immunization / Q000379:methods*; D015151:Immunoblotting; D051379:Mice; D008807:Mice, Inbred BALB C; D011817:Rabbits
chemical_list: D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D022121:Cholera Vaccines; D002772:Cholera Toxin
references: Clin Vaccine Immunol. 2011 Mar;18(3):477-82
references: 21177915
references: Nature. 2000 Feb 10;403(6770):665-8
references: 10688204
references: Nature. 1970 Aug 15;227(5259):680-5
references: 5432063
references: J Infect Dis. 1997 Dec;176 Suppl 2:S192-7
references: 9396710
references: Infect Immun. 2001 Jun;69(6):4125-8
references: 11349086
references: Infect Immun. 1998 Mar;66(3):938-43
references: 9488379
references: Lancet Infect Dis. 2006 Jun;6(6):361-73
references: 16728322
references: Infect Immun. 1991 Jul;59(7):2259-64
references: 2050397
references: Vaccine. 2006 Sep 29;24(40-41):6446-55
references: 16824653
references: Infect Immun. 2008 Jul;76(7):3170-5
references: 18426878
references: Adv Cyclic Nucleotide Res. 1977;8:85-118
references: 335847
references: Infect Immun. 2007 Jun;75(6):3070-3
references: 17438040
references: Clin Vaccine Immunol. 2010 Nov;17(11):1666-71
references: 20861330
references: J Infect Dis. 1997 Dec;176 Suppl 2:S103-5
references: 9396691
references: Infect Immun. 1988 Jan;56(1):99-105
references: 3335413
references: Infect Immun. 1994 Jan;62(1):15-23
references: 8262621
references: Clin Vaccine Immunol. 2008 May;15(5):859-62
references: 18353926
references: Vet Microbiol. 1994 Jul;41(1-2):183-8
references: 7801521
references: J Infect Dis. 1997 Dec;176 Suppl 2:S183-8
references: 9396708
references: Infect Immun. 1983 Feb;39(2):908-16
references: 6832823
references: Vaccine. 2006 May 1;24(18):3793-803
references: 16135393
references: Infect Immun. 1999 Nov;67(11):5799-805
references: 10531231
references: Infect Immun. 2009 Mar;77(3):1128-36
references: 19114545
references: Infect Immun. 1995 Sep;63(9):3731-5
references: 7642317
references: Mol Microbiol. 2000 Feb;35(3):529-41
references: 10672176
references: Infect Immun. 2000 Oct;68(10):5679-89
references: 10992471
references: Int J Food Microbiol. 2010 May 30;139 Suppl 1:S3-15
references: 20153070
references: Expert Rev Vaccines. 2009 May;8(5):625-45
references: 19397419
references: Clin Exp Immunol. 1998 Jan;111(1):81-90
references: 9472665
references: J Infect Dis. 1993 Sep;168(3):754-8
references: 8354916
references: Antimicrob Agents Chemother. 1993 Dec;37(12):2688-92
references: 8109936